Last deal

$2M

Amount

Grant

Stage

04.10.2010

Date

1

all rounds

$2M

Total amount

General

About Company
Maven Biotechnology develops real-time and label-free imaging technology for protein microarrays, cell-based assays and biomarker detection.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2000

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

Their diagnostic technology uses a polarimetric imaging system called LFIRE, which measures the refractive index of substances in real time. The system can detect small molecules, proteins, and cells, and is initially focused on immunoassays and various antigen-antibody analysis. Maven Biotechnology serves the diagnostics, pharmaceutical, research, and industrial sectors.
Contacts